Dr. Derick Kimathi, MBChB
Supervisors
Prof. George Warimwe
Prof. Sassy Molyneux
Sassy Molyneux, is an Associate Professor employed by Oxford University, UK, based at the Kenya Medical Research Institute-Wellcome Trust Research Programme in Kilifi, Kenya. She is a behavioural scientist, with a background in human geography. Her current main research interests include health system finance and governance, responsiveness of health systems to user and population priorities and concerns, and research ethics. A cross-cutting area of interest is producing new thinking, evidence and recommendations around initiatives aimed at strengthening accountability processes in biomedical research and health delivery in sub-Saharan Africa.
Prof. Philip Bejon
Email : PBejon@kemri-wellcome.org 
Phone : +07-5555-565 I first came to Kilifi in 2002 to conduct Phase I and IIb clinical trials of a candidate malaria vaccine based on viral vectors. I returned to the University of Oxford in 2006 to complete specialist clinical training as a clinical lecturer, and then was appointed as a senior fellow in the NIHR Oxford Biomedical Research Centre. These posts allowed me to remain active in malaria research, leading further trials of GSK’s candidate malaria vaccine “RTS,S”, and as a member of the Malaria Vectored Vaccine Consortium funded to test viral vectored malaria vaccines in several sites in Africa including Kilifi. An MRC Clinician-Scientist Fellowship, allowed me to return to be resident full-time in Kilifi in 2013, and I became Executive Director of the KEMRI-Wellcome Trust Research Programme in September 2014.
Mentors
Prof. Ifedayo Adetifa
Prof. Ifedayo Adetifa
Affiliation(s):
KEMRI – Wellcome – Trust, Kenya
London School of Hygiene & Tropical Medicine, UK
Ifedayo is a consultant pediatrician and infectious diseases epidemiologist. Prior to his arrival at the programme, he worked for a decade at the United Kingdom’s Medical Research Council Unit, The Gambia where he led clinical and field activities for the Tuberculosis (TB) epidemiology research including the TB case contact platform. His research interests there were delivery of TB diagnostics and care, assessment of novel diagnostics for TB infection and disease including biomarkers for disease and protection, and systematic reviews. In his last MRC role, he was the principal investigator on a £2.6million TB Epidemiology projects portfolio that included a nationwide TB prevalence survey and a community randomised trial to assess the impact of an enhanced TB case finding strategy on TB notification. He works full time at the Kilifi KEMRI-Wellcome Trust Research Programme on the Pneumococcal Vaccine Impact Study (PCVIS), and the Kilifi Vaccine Assessment Platform. He is also with the Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine. His current research interests are vaccine effectiveness studies, vaccine monitoring including issues of coverage, timeliness, and equity.
Prof. Caroline Jones
Affiliation(s):
Caroline Jones, a senior social scientist, joined the KEMRI-Wellcome Trust Research Programme in Kilifi from the London School of Hygiene and Tropical Medicine in February 2010. With a background in medical anthropology her research over the past 15 years has focused on treatment seeking and preventive behaviors for malaria and the factors that influence provider practices in sub-Saharan Africa. More recently she has been looking at the implement ability and sustainability of public health interventions, focusing on issues relating to social relationships, organizational structure and management and leadership. Research capacity strengthening and the promotion of the appropriate use of high quality social science research in the development and implementation of public health policy are major concerns underpinning much of her work. A key role in her current position is to contribute to building Kenyan and regional expertise to develop and lead such research.
Dr. Mainga Hamaluba
Derick Kimathi is a medical doctor, trained at the University of Nairobi. Derick joined KEMRI-Wellcome Trust Research Programme in 2017. He works within the arbovirus group, where he leads the human clinical trials. His interests are in tropical diseases prevention with a focus on emerging and re-emerging diseases; how to utilize vaccines for disease outbreak prevention and disease epidemic control.
Derick was awarded the TNF -Scholarship at the University of Oxford. His PhD is examining the immunogenicity of fractional doses for the Yellow Fever Vaccines in an attempt to redefine the minimum dose recommendation for the vaccine. His work also focuses on understanding the health policy processes at a macro level and how that influences vaccine use routinely and during epidemics.
Derick is the lead for the EDCTP funded multi-site study (NIFTY) with partners in KWTRP- Kenya, Epicentre- Uganda and France, UVRI-Uganda, Institut Pasteur de Dakar- Senegal and the University of Oxford.
- 51
- 66
- 48
- 104
- 44
- 423